Patents by Inventor Paula K. Rickert

Paula K. Rickert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GPCR differentially expressed in squamous cell carcinoma
    Publication number: 20030082653
    Abstract: The invention provides a cDNA which encodes a G protein-coupled receptor differentially expressed in squamous cell carcinoma. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of cancer. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Application
    Filed: April 11, 2002
    Publication date: May 1, 2003
    Inventors: Preeti G. Lal, Jennifer L. Jackson, Randi Krasnow, Paula K. Rickert
  • Transmembrane protein differentially expressed in prostate and lung tumors
    Publication number: 20030064397
    Abstract: The invention provides a cDNA which encodes a transmembrane protein differentially expressed in prostate and lung cancer. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of cancer, in particular, prostate or lung cancers. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Application
    Filed: July 24, 2002
    Publication date: April 3, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Kimberly M. Spancake, Paula K. Rickert, Preeti G. Lal, Craig H. Ison
  • Cathepsin differentially expressed in lung cancer
    Publication number: 20030036102
    Abstract: The invention is a new human cathepsin (LCAP), the cDNAs that encode LCAP, and antibodies that specifically bind LCAP that are used in methods for diagnosing and treating disorders of cell proliferation, particularly lung cancer, as associated with expression of LCAP. The invention provides expression vectors, host cells, and methods for making LCAP and agonists, antibodies and antagonists that specifically bind the protein.
    Type: Application
    Filed: May 8, 2002
    Publication date: February 20, 2003
    Inventors: Olga Bandman, Purvi Shah, Paula K. Rickert